{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:26:04Z","timestamp":1785741964125,"version":"3.56.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01 AG032952"],"award-info":[{"award-number":["P01 AG032952"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K76AG074878"],"award-info":[{"award-number":["K76AG074878"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["T32HP32715"],"award-info":[{"award-number":["T32HP32715"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11606-025-09413-w","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:37:44Z","timestamp":1739187464000},"page":"2964-2972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of Medicare Advantage vs Traditional Medicare with Clinical Outcomes Among Patients Hospitalized for Substance Use Disorders"],"prefix":"10.1007","volume":"40","author":[{"given":"Eden Y.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina X.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Z.","family":"Ayanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilsa E.","family":"Curto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Landon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"issue":"1","key":"9413_CR1","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/acer.14239","volume":"44","author":"AM White","year":"2020","unstructured":"White AM, Castle IJP, Hingson RW, Powell PA. Using Death Certificates to Explore Changes in Alcohol-Related Mortality in the United States, 1999 to 2017. Alcohol Clin Exp Res. 2020;44(1):178-187. https:\/\/doi.org\/10.1111\/acer.14239","journal-title":"Alcohol Clin Experimental Research."},{"key":"9413_CR2","unstructured":"National Institute on Drug Abuse. Drug Overdose Death Rates. June 30, 2023. Accessed December 20, 2023. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates"},{"issue":"8","key":"9413_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.15585\/mmwr.mm7308a1","volume":"73","author":"MB Esser","year":"2024","unstructured":"Esser MB, Sherk A, Liu Y, Naimi TS. Deaths from Excessive Alcohol Use - United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2024;73(8):154-161. https:\/\/doi.org\/10.15585\/mmwr.mm7308a1","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"2","key":"9413_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.amepre.2022.01.021","volume":"63","author":"WJ Parish","year":"2022","unstructured":"Parish WJ, Mark TL, Weber EM, Steinberg DG. Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment Barriers. Am J Prev Med. 2022;63(2):225-232. https:\/\/doi.org\/10.1016\/j.amepre.2022.01.021","journal-title":"Am J Prev Med."},{"key":"9413_CR5","unstructured":"Hospitalizations Involving Mental and Substance Use Disorders Among Adults, 2012 #191. Accessed September 12, 2022. https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb191-Hospitalization-Mental-Substance-Use-Disorders-2012.jsp"},{"key":"9413_CR6","doi-asserted-by":"publisher","first-page":"117822182211167","DOI":"10.1177\/11782218221116733","volume":"16","author":"A Acevedo","year":"2022","unstructured":"Acevedo A, Rodriguez Borja I, Alarcon Falconi TM, Carzo N, Naumova E. Hospitalizations for Alcohol and Opioid Use Disorders in Older Adults: Trends, Comorbidities, and Differences by Gender, Race, and Ethnicity. Subst Abuse. 2022;16:11782218221116733. https:\/\/doi.org\/10.1177\/11782218221116733","journal-title":"Subst Abuse."},{"issue":"2","key":"9413_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/ADM.0000000000000635","volume":"14","author":"K Crotty","year":"2020","unstructured":"Crotty K, Freedman KI, Kampman KM. Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. J Addict Med. 2020;14(2):99-112. https:\/\/doi.org\/10.1097\/ADM.0000000000000635","journal-title":"J Addict Med."},{"key":"9413_CR8","doi-asserted-by":"publisher","unstructured":"The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder | American Journal of Psychiatry. Accessed September 19, 2022. https:\/\/ajp.psychiatryonline.org\/doi\/https:\/\/doi.org\/10.1176\/appi.ajp.2017.1750101","DOI":"10.1176\/appi.ajp.2017.1750101"},{"key":"9413_CR9","doi-asserted-by":"publisher","unstructured":"Bernstein EY, Baggett TP, Trivedi S, Herzig SJ, Anderson TS. Pharmacologic Treatment Initiation Among Medicare Beneficiaries Hospitalized With Alcohol Use Disorder. Ann Intern Med. Published online June 27, 2023. https:\/\/doi.org\/10.7326\/M23-0641","DOI":"10.7326\/M23-0641"},{"issue":"1","key":"9413_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.amepre.2023.01.037","volume":"65","author":"H Samples","year":"2023","unstructured":"Samples H, Nowels MA, Williams AR, Olfson M, Crystal S. Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries. Am J Prev Med. 2023;65(1):19-29. https:\/\/doi.org\/10.1016\/j.amepre.2023.01.037","journal-title":"Am J Prev Med."},{"issue":"24","key":"9413_CR11","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMhpr2302315","volume":"389","author":"G Jacobson","year":"2023","unstructured":"Jacobson G, Blumenthal D. The Predominance of Medicare Advantage. New England J Med. 2023;389(24):2291-2298. https:\/\/doi.org\/10.1056\/NEJMhpr2302315","journal-title":"New England Journal of Medicine."},{"key":"9413_CR12","unstructured":"Medicare Advantage in 2023: Enrollment Update and Key Trends | KFF. Accessed August 14, 2023. https:\/\/www.kff.org\/medicare\/issue-brief\/medicare-advantage-in-2023-enrollment-update-and-key-trends\/"},{"key":"9413_CR13","unstructured":"Freed M, Sroczynski N, Published TN. Mental Health and Substance Use Disorder Coverage in Medicare Advantage Plans. KFF. April 28, 2023. Accessed December 20, 2023. https:\/\/www.kff.org\/mental-health\/issue-brief\/mental-health-and-substance-use-disorder-coverage-in-medicare-advantage-plans\/"},{"key":"9413_CR14","doi-asserted-by":"publisher","unstructured":"Taking Stock of Medicare Advantage: Special Needs Plans. https:\/\/doi.org\/10.26099\/z020-me79","DOI":"10.26099\/z020-me79"},{"issue":"7","key":"9413_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1377\/hlthaff.2022.01547","volume":"42","author":"JM Zhu","year":"2023","unstructured":"Zhu JM, Meiselbach MK, Drake C, Polsky D. Psychiatrist Networks In Medicare Advantage Plans Are Substantially Narrower Than In Medicaid And ACA Markets. Health Affairs. 2023;42(7):909-918. https:\/\/doi.org\/10.1377\/hlthaff.2022.01547","journal-title":"Health Affairs."},{"issue":"2","key":"9413_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1377\/hlthaff.2018.05226","volume":"38","author":"D Pelech","year":"2019","unstructured":"Pelech D, Hayford T. Medicare Advantage and Commercial Prices For Mental Health Services. Health Affairs. 2019;38(2):262-267. https:\/\/doi.org\/10.1377\/hlthaff.2018.05226","journal-title":"Health Affairs."},{"issue":"8","key":"9413_CR17","doi-asserted-by":"publisher","first-page":"e232517","DOI":"10.1001\/jamahealthforum.2023.2517","volume":"4","author":"EM Achola","year":"2023","unstructured":"Achola EM, Stevenson DG, Keohane LM. Postacute Care Services Use and Outcomes Among Traditional Medicare and Medicare Advantage Beneficiaries. JAMA Health Forum. 2023;4(8):e232517-e232517. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.2517","journal-title":"JAMA Health Forum."},{"issue":"3","key":"9413_CR18","doi-asserted-by":"publisher","first-page":"e235454","DOI":"10.1001\/jamahealthforum.2023.5454","volume":"5","author":"RA Prusynski","year":"2024","unstructured":"Prusynski RA, D\u2019Alonzo A, Johnson MP, Mroz TM, Leland NE. Differences in Home Health Services and Outcomes Between Traditional Medicare and Medicare Advantage. JAMA Health Forum. 2024;5(3):e235454. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.5454","journal-title":"JAMA Health Forum."},{"key":"9413_CR19","unstructured":"MedPAR | ResDAC. Accessed April 5, 2024. https:\/\/resdac.org\/cms-data\/files\/medpar"},{"key":"9413_CR20","unstructured":"Master Beneficiary Summary File (MBSF) Base | ResDAC. Accessed April 5, 2024. https:\/\/resdac.org\/cms-data\/files\/mbsf-base"},{"key":"9413_CR21","unstructured":"Identifying Medicare Managed Care Beneficiaries from the Master Beneficiary Summary or Denominator Files | ResDAC. Accessed April 5, 2024. https:\/\/resdac.org\/articles\/identifying-medicare-managed-care-beneficiaries-master-beneficiary-summary-or-denominator"},{"issue":"1","key":"9413_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1377\/hlthaff.2016.1027","volume":"36","author":"PJ Huckfeldt","year":"2017","unstructured":"Huckfeldt PJ, Escarce JJ, Rabideau B, Karaca-Mandic P, Sood N. Less Intense Postacute Care, Better Outcomes For Enrollees In Medicare Advantage Than Those In Fee-For-Service. Health Affairs. 2017;36(1):91-100. https:\/\/doi.org\/10.1377\/hlthaff.2016.1027","journal-title":"Health Affairs."},{"key":"9413_CR23","unstructured":"ARDI Methods | Alcohol and Public Health | CDC. April 18, 2022. Accessed October 19, 2022. https:\/\/www.cdc.gov\/alcohol\/ardi\/methods.html"},{"key":"9413_CR24","unstructured":"Owens PL, Weiss AJ, Barrett ML. Table 2, ICD-10-CM diagnosis codes defining opioid-related inpatient stays. May 26, 2020. Accessed April 5, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559382\/table\/sb258.tab4\/"},{"key":"9413_CR25","doi-asserted-by":"publisher","first-page":"CD001333","DOI":"10.1002\/14651858.CD001333.pub3","volume":"2","author":"S Minozzi","year":"2011","unstructured":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2011;(2):CD001333. https:\/\/doi.org\/10.1002\/14651858.CD001333.pub3","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"9413_CR26","doi-asserted-by":"publisher","first-page":"e2314328","DOI":"10.1001\/jamanetworkopen.2023.14328","volume":"6","author":"EA Taylor","year":"2023","unstructured":"Taylor EA, Cantor JH, Bradford AC, Simon K, Stein BD. Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes. JAMA Network Open. 2023;6(5):e2314328. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.14328","journal-title":"JAMA Network Open."},{"issue":"4","key":"9413_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/jama.288.4.455","volume":"288","author":"JS Benner","year":"2002","unstructured":"Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term Persistence in Use of Statin Therapy in Elderly Patients. JAMA. 2002;288(4):455-461. https:\/\/doi.org\/10.1001\/jama.288.4.455","journal-title":"JAMA."},{"issue":"3","key":"9413_CR28","first-page":"27","volume":"29","author":"C Eicheldinger","year":"2008","unstructured":"Eicheldinger C, Bonito A. More accurate racial and ethnic codes for Medicare administrative data. Health Care Financ Rev. 2008;29(3):27-42.","journal-title":"Health Care Financ Rev."},{"issue":"19","key":"9413_CR29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1056\/NEJMsa2212412","volume":"388","author":"ML Barnett","year":"2023","unstructured":"Barnett ML, Meara E, Lewinson T, et al. Racial Inequality in Receipt of Medications for Opioid Use Disorder. New England J Med. 2023;388(19):1779-1789. https:\/\/doi.org\/10.1056\/NEJMsa2212412","journal-title":"New England Journal of Medicine."},{"key":"9413_CR30","unstructured":"Robert Graham Center - Policy Studies in Family Medicine & Primary Care. Social deprivation index (SDI). Published online November 5, 2018. Accessed November 16, 2023. https:\/\/www.graham-center.org\/rgc\/maps-data-tools\/sdi\/social-deprivation-index.html"},{"key":"9413_CR31","unstructured":"Agency for Healthcare Research and Quality. Clinical Classifications Software (CCS) for ICD-10-CM. Accessed May 30, 2024. https:\/\/hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/comorbidity_icd10.jsp"},{"issue":"4","key":"9413_CR32","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1077558717692103","volume":"75","author":"RM Henke","year":"2018","unstructured":"Henke RM, Karaca Z, Gibson TB, et al. Medicare Advantage and Traditional Medicare Hospitalization Intensity and Readmissions. Med Care Res Rev. 2018;75(4):434-453. https:\/\/doi.org\/10.1177\/1077558717692103","journal-title":"Med Care Res Rev."},{"issue":"12","key":"9413_CR33","doi-asserted-by":"publisher","first-page":"524","DOI":"10.37765\/ajmc.2020.88540","volume":"26","author":"PD Jacobs","year":"2020","unstructured":"Jacobs PD, Basu J. Medicare Advantage and postdischarge quality: evidence from hospital readmissions. Am J Manag Care. 2020;26(12):524-529. https:\/\/doi.org\/10.37765\/ajmc.2020.88540","journal-title":"Am J Manag Care."},{"issue":"12","key":"9413_CR34","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jamacardio.2020.3638","volume":"5","author":"JF Figueroa","year":"2020","unstructured":"Figueroa JF, Wadhera RK, Frakt AB, et al. Quality of Care and Outcomes Among Medicare Advantage vs Fee-for-Service Medicare Patients Hospitalized With Heart Failure. JAMA Cardiology. 2020;5(12):1349-1357. https:\/\/doi.org\/10.1001\/jamacardio.2020.3638","journal-title":"JAMA Cardiology."},{"issue":"21","key":"9413_CR35","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1001\/jama.2022.20982","volume":"328","author":"BE Landon","year":"2022","unstructured":"Landon BE, Anderson TS, Curto VE, et al. Association of Medicare Advantage vs Traditional Medicare With 30-Day Mortality Among Patients With Acute Myocardial Infarction. JAMA. 2022;328(21):2126-2135. https:\/\/doi.org\/10.1001\/jama.2022.20982","journal-title":"JAMA."},{"key":"9413_CR36","doi-asserted-by":"publisher","unstructured":"Barth S, Monson M. Integrating Care In Dual Eligible Special Needs Plans: A Bigger Toolbox For States. Health Affairs Forefront. https:\/\/doi.org\/10.1377\/forefront.20220720.555501","DOI":"10.1377\/forefront.20220720.555501"},{"issue":"9","key":"9413_CR37","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1377\/hlthaff.2022.00463","volume":"41","author":"ET Roberts","year":"2022","unstructured":"Roberts ET, Mellor JM. Differences In Care Between Special Needs Plans And Other Medicare Coverage For Dual Eligibles. Health Aff (Millwood). 2022;41(9):1238-1247. https:\/\/doi.org\/10.1377\/hlthaff.2022.00463","journal-title":"Health Aff (Millwood)."},{"issue":"12","key":"9413_CR38","doi-asserted-by":"publisher","first-page":"e234583","DOI":"10.1001\/jamahealthforum.2023.4583","volume":"4","author":"ET Roberts","year":"2023","unstructured":"Roberts ET, Xue L, Lovelace J, et al. Changes in Care Associated With Integrating Medicare and Medicaid for Dual-Eligible Individuals. JAMA Health Forum. 2023;4(12):e234583. https:\/\/doi.org\/10.1001\/jamahealthforum.2023.4583","journal-title":"JAMA Health Forum."},{"key":"9413_CR39","doi-asserted-by":"publisher","unstructured":"Steinberg D, Weber E, Woodworth A. Medicare\u2019s Discriminatory Coverage Policies For Substance Use Disorders. Health Affairs Fore. https:\/\/doi.org\/10.1377\/forefront.20210616.166523","DOI":"10.1377\/forefront.20210616.166523"},{"issue":"1","key":"9413_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1056\/NEJMp1813961","volume":"380","author":"Corey S Davis","year":"2019","unstructured":"Davis Corey S. The SUPPORT for Patients and Communities Act \u2014 What Will It Mean for the Opioid-Overdose Crisis? New England J Med. 2019;380(1):3-5. https:\/\/doi.org\/10.1056\/NEJMp1813961","journal-title":"New England J Med."},{"issue":"16","key":"9413_CR41","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1056\/NEJMc2312906","volume":"390","author":"K-P Chua","year":"2024","unstructured":"Chua Kao-Ping, Bicket Mark C., Bohnert Amy S.B., Conti Rena M., Lagisetty Pooja, Nguyen Thuy D. Buprenorphine Dispensing after Elimination of the Waiver Requirement. New England J Med. 2024;390(16):1530-1532. https:\/\/doi.org\/10.1056\/NEJMc2312906","journal-title":"New England J Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09413-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09413-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:02:12Z","timestamp":1770685332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09413-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["9413"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09413-w","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Bernstein received personal fees from Alosa Health outside of submitted work. Dr. Ayanian reports serving on the board of Physicians Health Plan representing his employer (the University of Michigan) without additional compensation; grants from the NIA during the conduct of the study; grants from the Michigan Department of Health and Human Services and the Merck Foundation; personal fees from the JAMA Network, Harvard University, the University of Massachusetts Medical School, the University of California San Diego, and Emory University; and non-financial support from the National Academy of Medicine and from AcademyHealth outside the submitted work. Dr Curto reported grants from the NIA during the conduct of the study. Dr. Anderson reported grants from the NIA, the American College of Cardiology, and the Boston Pepper Center outside the submitted work and personal fees from JAMA Network and the American Medical Student Association. Dr. Landon reports receiving speaking fees from CVS\/Aetna for a topic unrelated to the current analysis; grants from the National Institute on Aging (NIA), the National Cancer Institute, and the Agency for Healthcare Research and Quality outside the submitted work; and serving on the following boards without compensation: board of managers of Physician Performance LLC, the contracts and payments committee of Physician Performance LLC, the contracts and finance committee of the Beth Israel Lahey Performance Network, and the board of directors of Health Resources in Action.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The NIA had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The research reported in this publication was supported by the National Institute on Aging of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}